Ebvallo approval ushers in off-the-shelf T-cell immunotherapies
Patient-derived CAR-T immunotherapies have dominated the cancer immunotherapy space over the last decade. The EU…
Patient-derived CAR-T immunotherapies have dominated the cancer immunotherapy space over the last decade. The EU…
iOnctura BV, a clinical-stage biotech developing novel cancer therapies, has been granted €17.5 million ($18.6…
Over the decades, the EU has spearheaded the adoption of advanced therapy medicinal products (ATMPs)…
The European Commission (EC) has expanded the marketing authorization for Dupixent (dupilumab) in the European…
BC Platforms (BCP), a provider of healthcare data management and analytics, has been chosen as…
RCSI University of Medicine and Health Sciences and FutureNeuro are co-leading, with University College Dublin,…
Sanofi’s treatment, Enjaymo, for hemolytic anemia in adult patients with cold agglutinin disease (CAD), has…
The European Genomic Data Infrastructure (GDI) project kicked off today in Brussels, Belgium. The new…
A drug being developed jointly by Sanofi and AstraZeneca for the prevention of respiratory syncytial…
Marketing authorization has been granted to a drug to treat relapsed/refractory (R/R) marginal zone lymphoma…
Swedish biotech company Oncopeptides AB has initiated the commercial launch of Pepaxti (melphalan flufenamide) in…
A project to tackle the biodiversity crisis using DNA data, genomic science that will fundamentally…